Evidence map›Paper›PMID 38849503›Full record

ArticleScientific reports2024

Glucose-fed microbiota alters C. elegans intestinal epithelium and increases susceptibility to multiple bacterial pathogens.

Samuel F Kingsley, Yonghak Seo, Alicia Wood, Khursheed A Wani, Xavier Gonzalez, Javier Irazoqui, Steven E Finkel, Heidi A Tissenbaum

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. High Nutritional Conditions Influence Feeding Plasticity in Pristionchus pacificus and Render Worms Non-Predatory.Journal of experimental zoology. Part B, Molecular and developmental evolution · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Samuel F KingsleyDepartment of Molecular, Cell and Cancer Biology, UMass Chan Medical School, Worcester, MA, 01605, USA.
Yonghak SeoDepartment of Molecular, Cell and Cancer Biology, UMass Chan Medical School, Worcester, MA, 01605, USA.
Alicia WoodDepartment of Molecular, Cell and Cancer Biology, UMass Chan Medical School, Worcester, MA, 01605, USA.
Khursheed A WaniDepartment of Microbiology and Physiological Systems, UMass Chan Medical School, Worcester, MA, 01605, USA.
Xavier GonzalezDepartment of Microbiology and Physiological Systems, UMass Chan Medical School, Worcester, MA, 01605, USA.
Javier IrazoquiDepartment of Microbiology and Physiological Systems, UMass Chan Medical School, Worcester, MA, 01605, USA.
Steven E FinkelMolecular and Computational Biology Section, Department of Biological Sciences, University of Southern California, Los Angeles, CA, 90089-2910, USA.
Heidi A TissenbaumDepartment of Molecular, Cell and Cancer Biology, UMass Chan Medical School, Worcester, MA, 01605, USA. Heidi.Tissenbaum@umassmed.edu.

Funding

Role of MiT Transcription Factors in Host Defense Against Bacterial InfectionR01GM101056 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI IRAZOQUI, JAVIER ELBIO · 2012 to 2022
$3.9M
Innate Immunity Training ProgramT32AI095213 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SILVERMAN, NEAL · 2011 to 2025
$2.5M
Mechanisms of the gut-brain axis that regulate innate immunityR35GM149284 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Javier Elbio Irazoqui · 2023 to 2026
$1.7M
Dissecting connections between age, health and Alzheimer's diseaseR21AG067317 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI TISSENBAUM, HEIDI A · 2020 to 2021
$618k
FLAVIN-CONTAINING MONO-OXYGENASES AS NOVEL INNATE IMMUNITY EFFECTORSR21AI169842 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI IRAZOQUI, JAVIER ELBIO · 2023 to 2024
$461k
National Institutes of Aging,United States 5R21AG067317NIAID NIH HHS R21 AI169842NIAID NIH HHS T32 AI095213NIGMS NIH HHS R01 GM101056NIGMS NIH HHS R35 GM149284U.S. Army Research Office W911NF1210321
6 · The paper itself

Abstract

Overconsumption of dietary sugar can lead to many negative health effects including the development of Type 2 diabetes, metabolic syndrome, cardiovascular disease, and neurodegenerative disorders. Recently, the human intestinal microbiota, strongly associated with our overall health, has also been known to be affected by diet. However, mechanistic insight into the importance of the human intestinal microbiota and the effects of chronic sugar ingestion has not been possible largely due to the complexity of the human microbiome which contains hundreds of types of organisms. Here, we use an interspecies C. elegans/E. coli system, where E. coli are subjected to high sugar, then consumed by the bacterivore host C. elegans to become the microbiota. This glucose-fed microbiota results in a significant lifespan reduction accompanied by reduced healthspan (locomotion), reduced stress resistance, and changes in behavior and feeding. Lifespan reduction is also accompanied by two potential major contributors: increased intestinal bacterial density and increased concentration of reactive oxygen species. The glucose-fed microbiota accelerated the age-related development of intestinal cell permeability, intestinal distention, and dysregulation of immune effectors. Ultimately, the changes in the intestinal epithelium due to aging with the glucose-fed microbiota results in increased susceptibility to multiple bacterial pathogens. Taken together, our data reveal that chronic ingestion of sugar, such as a Western diet, has profound health effects on the host due to changes in the microbiota and may contribute to the current increased incidence of ailments including inflammatory bowel diseases as well as multiple age-related diseases.

Indexed as

Caenorhabditis elegansEscherichia coliGastrointestinal MicrobiomeGlucoseIntestinal MucosaAnimalsDisease SusceptibilityLongevityReactive Oxygen SpeciesGlucoseReactive Oxygen Species

Identifiers

PMID38849503
PMCPMC11161463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.